![Medpace Holdings Inc](/common/images/company/N_MEDP.png)
Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin Am... Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America. Show more
Apple (NASDAQ:AAPL) – Smartphone shipments from Apple in China fell 19% in the first quarter due to competition from Huawei. Its market share decreased to 15.7%, nearly matching that of...
Revenue of $511.0 million in the first quarter of 2024 increased 17.7% from revenue of $434.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net...
U.S. index futures saw significant gains in Monday’s pre-market trading, signaling a potential stabilization on Wall Street after a six-session streak of losses for the S&P 500 and the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.18 | 1.79369956781 | 400.29 | 414.8099 | 393.69 | 261300 | 404.78170107 | CS |
4 | 18.91 | 4.86668725551 | 388.56 | 414.8099 | 379.15 | 191408 | 398.527659 | CS |
12 | 18.18 | 4.67004032983 | 389.29 | 421 | 355.79 | 209157 | 395.53004241 | CS |
26 | 94.87 | 30.3486884197 | 312.6 | 421 | 277.72 | 227563 | 377.08419908 | CS |
52 | 184.17 | 82.4764890282 | 223.3 | 421 | 221.33 | 252599 | 311.43093142 | CS |
156 | 226.64 | 125.333185865 | 180.83 | 421 | 126.945 | 289807 | 219.65708085 | CS |
260 | 345.15 | 553.835044929 | 62.32 | 421 | 58.72 | 289322 | 173.01155411 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.